Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Weight Loss × 2,2,2',4'-tetrachloroacetophenone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 1 Pediatric Obesity 1 Obesity 1

Interventions

Tirzepatide 1 Population Groups 1 Olanzapine 1 Megestrol Acetate 1 Magnetic Resonance Spectroscopy 1 Counseling 1 Cognitive Behavioral Therapy 1 Caloric Restriction 1 Breast Implants 1 2,2,2',4'-tetrachloroacetophenone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07144800 2026-02-02

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting

Obesity, Weight Loss, Pediatric Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡